COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 243.3 | 4 | 0035-0148 | 217.28 | 148.11 | 423 | 76.43 | 0.910 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 249.6 | 4 | 0036-0153 | 718.54 | 153.51 | 431 | 82.77 | 0.791 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 235.0 | 4 | 0037-0159 | 843.33 | 158.44 | 853 | 112.71 | 0.844 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 301.9 | 4 | 0038-0158 | 145.77 | 159.32 | 864 | 116.23 | 0.804 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 487.6 | 4 | 0039-0168 | 270.56 | 168.62 | 924 | 119.88 | 0.808 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 695.5 | 4 | 0040-0168 | 358.99 | 168.27 | 488 | 84.33 | 0.862 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 324.9 | 4 | 0041-0166 | 664.94 | 166.66 | 434 | 79.50 | 0.863 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 703.3 | 4 | 0042-0172 | 406.55 | 172.28 | 479 | 82.67 | 0.881 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 274.1 | 4 | 0043-0173 | 716.05 | 172.21 | 435 | 79.11 | 0.873 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 439.1 | 4 | 0044-0175 | 24.26 | 175.99 | 395 | 75.26 | 0.876 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 337.5 | 4 | 0045-0180 | 572.58 | 180.40 | 513 | 88.91 | 0.815 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 294.9 | 4 | 0046-0181 | 609.93 | 180.72 | 439 | 78.08 | 0.905 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 443.1 | 4 | 0047-0184 | 543.08 | 183.36 | 499 | 87.40 | 0.821 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 205.6 | 4 | 0048-0185 | 883.86 | 185.73 | 451 | 79.26 | 0.902 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 795.6 | 4 | 0049-0195 | 792.79 | 195.10 | 446 | 78.91 | 0.900 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 587.4 | 4 | 0050-0195 | 215.19 | 194.82 | 391 | 71.60 | 0.958 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 1248.5 | 4 | 0051-0196 | 183.93 | 196.02 | 391 | 72.18 | 0.943 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 716.1 | 4 | 0052-0198 | 266.48 | 198.05 | 625 | 94.77 | 0.874 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 300.7 | 4 | 0053-0197 | 858.04 | 196.41 | 430 | 79.50 | 0.855 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 255.1 | 4 | 0054-0201 | 452.45 | 201.56 | 438 | 79.50 | 0.871 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 274.5 | 4 | 0055-0201 | 145.36 | 200.44 | 437 | 79.26 | 0.874 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 347.5 | 4 | 0056-0202 | 916.56 | 202.45 | 431 | 77.26 | 0.907 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 215.7 | 4 | 0057-0213 | 537.22 | 213.14 | 511 | 91.40 | 0.769 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 206.3 | 4 | 0058-0212 | 735.76 | 212.22 | 435 | 81.50 | 0.823 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS240; pS244) / Alexa Fluor 488 | rabbit IgG(H+L) / goat / cross-adsorbed | FITC | S6 (pS240; pS244) | | 438.6 | 4 | 0059-0225 | 336.76 | 224.68 | 832 | 114.81 | 0.793 |